title: Re: "Early benefit assessment of new drugs in Germany--results from 2011 to 2012" [Health Policy 116 (2-3) (2014) 147-153].
authors.affiliation: German Association of Research-based Pharmaceutical Companies (vfa), Berlin, Germany. Electronic address: t.orben@vfa.de.
authors.forename: Tina
authors.initials: T
authors.lastname: Orben
authors.affiliation: German Association of Research-based Pharmaceutical Companies (vfa), Berlin, Germany.
authors.forename: Andrej
authors.initials: A
authors.lastname: Rasch
authors.affiliation: German Association of Research-based Pharmaceutical Companies (vfa), Berlin, Germany.
authors.forename: Charalabos-Markos
authors.initials: CM
authors.lastname: Dintsios
mesh_terms: D017277:Drug Approval / Q000379:methods*; D006801:Humans